Sun.May 07, 2023

article thumbnail

Happy National Nurses Week!

OctariusRx

Happy National Nurses Week to all our nursing colleagues, clients, friends, and family. National Nurses Week is from Saturday May 6 th through May 12th, Florence Nightingale ’s birthday. As usual, the OctariusRx team is taking time to recognize and celebrate all the contributions and sacrifices nurses make daily. Cheers to all nurses! Because you consistently put the well-being of others before your own, you are our heroes.

70
article thumbnail

How to Ease Leg Cramps with Mustard

The People's Pharmacy

When a leg cramp strikes in the middle of the night, it results in a rude awakening. Sometimes the pain can bring tears to a person’s eyes. Finding relief is just as urgent if you are in the middle of an important activity, such as running, biking or scuba diving. Consequently, a way to ease leg cramps quickly and effectively is most welcome! Scuba Diver Uses Mustard to Ease Leg Cramps: Q.

72
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rise and Recognition

PharmExec

This year marks my first involvement in Pharmaceutical Executive’s Emerging Pharma Leaders (EPL) Awards, and what a ride it has been. We received so many wonderful nominations, and it’s always humbling to learn about some of the intricacies of the research that’s being done as well as the accomplishments of both current leaders and up-and-coming leaders.

52
article thumbnail

Formosa, AimMax submit NDA to FDA for new pain therapy

Pharmaceutical Technology

Formosa Pharmaceuticals along with AimMax Therapeutics has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for APP13007, a new formulation to treat inflammation and pain after ocular surgery. APP13007 is an aqueous nanosuspension formulation of the potent corticosteroid, clobetasol propionate (0.05%). The homogeneous nanosuspension looks like a solution that provides improved comfort to the eyes and helps drug penetrate well into ocular tissues.

FDA 52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

TO BE CONTINUED (!?): DEA Announces It is Issuing a “Temporary Rule” to Address Telemedicine Flexibilities After the End of the COVID-19 Pandemic Emergency

The FDA Law Blog

By Karla L. Palmer — On May 3, 2023, DEA’s Administrator Anne Milgram issued a very brief and lightly publicized statement announcing that DEA intends to issue a “temporary rule” extending telemedicine flexibilities that existed during the COVID-19 Emergency Declaration, which Declaration is set to expire on May 11, 2023. Most notably for the millions of patients who, for over three years, have depended on telemedicine solutions to receive needed controlled substance medications, the Declaratio

article thumbnail

As FREE As Amazon Will Let Me! MPJE Federal Law Book – Offer Will End Soon!

Med Ed 101

I enjoy giving back to those who follow the blog closely and I hope this will help a lot of students and pharmacists with their MPJE preparations! I’m pricing the 2nd Edition (Bigger and Better than the first edition!) of MPJE Master as cheap as Amazon will let me. Spoiler alert – It is $0.99! […] The post As FREE As Amazon Will Let Me!

52

More Trending

article thumbnail

Bliss Biopharmaceutical Entered into a Clinical Trial Collaboration Agreement with Eisai for BB-1701 to Treat Cancers

PharmaShots

Shots: BlissBio will receive up front & milestones. If Eisai exercises its option, BlissBio will also receive an option exercise fee, ~$2B in development & commercial milestones along with royalties. Both companies will conduct co-development activities related to BB-1701 through an option period Upon the option exercise, Eisai to get a right globally (excl.

40
article thumbnail

Pharma á la carte – 5/9/23

The Honest Apothecary

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. I might throw in a something off-topic from time to time which I found while wandering throughout the endless hallways and corridors of the internet. All article shared will be free to read and not locked behind an annoying paywall.